{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:16:03Z","timestamp":1793654163913,"version":"4.5.1"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Eclampsia is a multisystemic disease associated with various complications which individually or in combination can lead to maternal\/fetal morbidity and mortality. Developed countries and some developing countries were largely successful in reducing the incidence of eclampsia. Developing countries especially those in Sub-Saharan Africa (SSA) are still dealing with high incidence of eclampsia. The question is why have the incidence and mortality of eclampsia remained high in SSA? The risk factors for this disease are globally the same but a critical assessment showed that there are certain risk factors that\u00a0are common in Sub-Saharan Africa (multiple pregnancy, sickle cell disease, pregnancies at the extremes of reproductive age, pre-existing vasculitis). In addition, there are compounding factors (illiteracy, poverty, superstitious beliefs, poor prenatal care services, poorly trained manpower and lack of facilities to cater for patients). Addressing the menace of this disease require a holistic approach which among others, includes education to address beliefs and reduce harmful practices, poverty alleviation which will improve the ability for communities to afford health care services. Improving transport services to convey patients quickly to facilities on time when there is need. Improving the health infrastructure, building more facilities, providing trained and motivated manpower and regular supply of quality essential drugs for the management of the disease. This review is meant to analyze factors prevalent in Sub-Saharan that hinder reducing incidence of the disease and provide comprehensive and cost-effective solutions.<\/jats:p>","DOI":"10.1515\/jpm-2022-0053","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:59:20Z","timestamp":1661299160000},"page":"300-304","source":"Crossref","is-referenced-by-count":4,"title":["Eclampsia a preventable tragedy: an African overview"],"prefix":"10.1515","volume":"51","author":[{"given":"Labaran Dayyabu","family":"Aliyu","sequence":"first","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar Saidu","family":"Kadas","sequence":"additional","affiliation":[{"name":"Abubakar Tafawa Balewa University Teaching Hospital , Bauchi , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdulsalam","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauwa Musa","family":"Abdulllahi","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubaida","family":"Farouk","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-953X","authenticated-orcid":false,"given":"Fatima","family":"Usman","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael Avidime","family":"Attah","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtala","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Kawu","family":"Magashi","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Miko","sequence":"additional","affiliation":[{"name":"Bayero University , Kano , Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2023033123593982632_j_jpm-2022-0053_ref_001","unstructured":"Committee Opinion No. 767. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2019;133:e174\u201380. https:\/\/doi.org\/10.1097\/AOG.0000000000003075.2."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_002","unstructured":"WHO, UNFPA, UNICEF. Managing complications in pregnancy and\u00a0childbirth: a guide for midwives and doctors, 2nd ed. Geneva:\u00a0World Health Organization; 2017. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/255760 [Accessed 22 Jan 2022]."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_003","unstructured":"WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011. Available from: http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548335_eng.pdf [Accessed 18 Jan 2022]."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_004","doi-asserted-by":"crossref","unstructured":"Duley, L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 2003;67:161\u201376. https:\/\/doi.org\/10.1093\/bmb\/ldg005.","DOI":"10.1093\/bmb\/ldg005"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_005","doi-asserted-by":"crossref","unstructured":"Duley, L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130\u20137. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010.","DOI":"10.1053\/j.semperi.2009.02.010"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_006","doi-asserted-by":"crossref","unstructured":"Steegers, EA, von Dadelszen, P, Duvekot, JJ, Pijnenborg, R. Pre-eclampsia. Lancet 2010;21376:631\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(10)60279-6.","DOI":"10.1016\/S0140-6736(10)60279-6"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_007","unstructured":"World Health Organization. WHO recommendations: drug treatment for severe hypertension in pregnancy: World Health Organization. License: CC BY-NC-SA 3.0 IGO; 2018. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/277234 [Accessed 24 Jan 2022]."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_008","doi-asserted-by":"crossref","unstructured":"Khan, KS, Wojdyla, D, Say, L, G\u00fclmezoglu, AM, Van Look, PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;1:367\u20131074. https:\/\/doi.org\/10.1016\/s0140-6736(06)68397-9.","DOI":"10.1016\/S0140-6736(06)68397-9"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_009","doi-asserted-by":"crossref","unstructured":"Say, L, Chou, D, Gemmill, A, Tuncalp, O, Moller, AB, Daniels, J, et al.. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health 2014;2:e323\u201333. https:\/\/doi.org\/10.1016\/s2214-109x(14)70227-x.","DOI":"10.1016\/S2214-109X(14)70227-X"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_010","unstructured":"World Health Organization. Make every mother and child count. Geneva, Switzerland; 2005. Available from: https:\/\/www.who.int\/whr\/2005\/whr2005-en.pdf [Accessed 22 Jan 2022]."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_011","doi-asserted-by":"crossref","unstructured":"Thaddeus, S, Maine, D. Too far to walk: maternal mortality in context. Soc Sci Med 1994;38:1091\u2013110. https:\/\/doi.org\/10.1016\/0277-9536(94)90226-7.","DOI":"10.1016\/0277-9536(94)90226-7"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_012","doi-asserted-by":"crossref","unstructured":"Nyirenda, J, Kasonka, L, Walika, B. Maternal complications of severe preeclampsia at a tertiary level hospital in Zambia. Med J Zambia 2019;46:117\u201323.","DOI":"10.55320\/mjz.46.2.507"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_013","doi-asserted-by":"crossref","unstructured":"Kim, YM, Ansari, N, Kols, A, Tappis, H, Currie, S, Zainullah, P, et al.. Prevention and management of severe preeclampsia\/eclampsia in Afganistan. BMC Pregnancy Childbirth 2013;13:186\u201395. https:\/\/doi.org\/10.1186\/1471-2393-13-186.","DOI":"10.1186\/1471-2393-13-186"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_014","doi-asserted-by":"crossref","unstructured":"Piel, FB, Hay, SI, Gupta, S, Weatherall, DJ, Williams, TN. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med 2013;10:e1001484. https:\/\/doi.org\/10.1371\/journal.pmed.1001484.","DOI":"10.1371\/journal.pmed.1001484"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_015","doi-asserted-by":"crossref","unstructured":"Odame, I. Perspective: we need a global solution. Nature 2014;515:S10. https:\/\/doi.org\/10.1038\/515S10a.","DOI":"10.1038\/515S10a"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_016","doi-asserted-by":"crossref","unstructured":"Tshilolo, L, Kafando, E, Sawadogo, M, Cotton, F, Vertongen, F, Ferster, A, et al.. Neonatal screening and clinical care programmes for sickle cell disorders in subsaharan Africa: lessons from pilot studies. Publ Health 2008;122:933\u201341. https:\/\/doi.org\/10.1016\/j.puhe.2007.12.005.","DOI":"10.1016\/j.puhe.2007.12.005"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_017","doi-asserted-by":"crossref","unstructured":"Kadima, BT, Gini Ehungu, JL, Ngiyulu, RM, Ekulu, PM, Aloni, MN. High rate of sickle cell anaemia in Sub-Saharan Africa underlines the need to screen all children with severe anaemia for the disease. Acta Paediatr 2015;104:1269\u201373. https:\/\/doi.org\/10.1111\/apa.13040.","DOI":"10.1111\/apa.13040"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_018","unstructured":"Nigerian National Demographic Survey 2003. Available from: https:\/\/microdata.worldbank.org\/index.php\/catalog\/1458 [Accessed 21 Jan 2022]."},{"key":"2023033123593982632_j_jpm-2022-0053_ref_019","doi-asserted-by":"crossref","unstructured":"Raghupathy, S. Education and the use of maternal health care in Thailand. Soc Sci Med 1996;43:459\u201371. https:\/\/doi.org\/10.1016\/0277-9536(95)00411-4.","DOI":"10.1016\/0277-9536(95)00411-4"},{"key":"2023033123593982632_j_jpm-2022-0053_ref_020","doi-asserted-by":"crossref","unstructured":"Obermeyer, CM, Potter, JE. Maternal health care utilization in Jordan: a study of patterns and determinants. Stud Fam Plann 1991;22:177\u201387. https:\/\/doi.org\/10.2307\/1966644.","DOI":"10.2307\/1966644"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0053\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0053\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T13:40:10Z","timestamp":1680356410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2022-0053\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,8]]},"published-print":{"date-parts":[[2023,3,28]]}},"alternative-id":["10.1515\/jpm-2022-0053"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2022-0053","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]}}}